{
  "id": 156532,
  "title": "Clinical-guided deep learning framework for diabetic retinopathy: integrating lesion-aware attention, adversarial augmentation, and uncertainty quantification",
  "url": "https://urgent.news/2026/08/05/clinical-guided-deep-learning-framework-for-diabetic-retinopathy",
  "topic": "ai",
  "section": "AI",
  "published": "2026-08-05T00:00:00.000Z",
  "source": {
    "name": "Scientific Reports",
    "slug": "scientific-reports",
    "url": "https://www.nature.com/articles/s41598-026-58690-w"
  },
  "original_language": "en",
  "account": "Diabetic retinopathy (DR) is an escalating global health concern, driven by the increasing prevalence of diabetes. Existing automated screening systems often fall short in providing interpretable lesion-level analysis, robustness against class imbalance, and reliable uncertainty estimation, hindering their practical application in real-world clinical settings. In response, researchers have developed a clinical-guided deep learning framework called CG-DRNet, which aims to improve reliable and explainable DR severity detection while enabling early-stage detection, particularly mild nonproliferative diabetic retinopathy (NPDR).\n\nCG-DRNet incorporates lesion-aware attention, adversarial data augmentation, and Bayesian uncertainty measurement to tackle the challenges of DR diagnosis. By employing a multi-task deep learning framework and a lesion-aware attention network, CG-DRNet explicitly predicts microaneurysms, hemorrhages, exudates, and neovascularization. To address the extreme imbalance of classes, a conditional generative adversarial network (CWGAN-GP) is utilized to generate clinically realistic images of minority classes in fundus images. Monte Carlo dropout is employed to model Bayesian uncertainty and estimate predictive confidence, while an uncertainty-informed semi-supervised learning strategy enhances data efficiency.\n\nEvaluation of CG-DRNet was performed on publicly available fundus image datasets, including APTOS 2019, Messidor-2, and Clinical metadata. The framework achieved impressive results, reaching 93.8% accuracy on APTOS 2019 and 91.2% on Messidor-2, with only a 2.6% difference between the generalization and original model's performance. The macro F1-score was 0.891, and the quadratic weighted kappa was 0.912. The referable DR detection AUC was 0.963, and the expected calibration error was only 0.034. CG-DRNet demonstrated an 84.7% sensitivity in detecting Grade 2+ DR, with an inference time of just 67 milliseconds, making it a viable solution for clinical use.\n\nDiabetic retinopathy is a neurovascular complication resulting from processes such as AGE accumulation, PKC activation, and VEGF upregulation, which degrade the inner blood-retinal barrier. Typical appearances include microaneurysms, intraretinal hemorrhages, hard and soft exudates, and neovascular proliferation. Currently, approximately 90 million people worldwide have DR, with one-third likely to develop it by 2040. DR is a leading cause of vision loss among working-age adults globally and carries an immense burden on healthcare systems, particularly in resource-constrained environments.\n\nEarly diagnosis of DR is crucial, as landmark DCCT and UKPDS trials have shown that maintaining HbA1c levels below 7% can decrease the risk of DR by up to 76% in type 1 diabetes and 25% in type 2 diabetes. However, global screening coverage remains low due to labor shortages, geographic differences, and inter-observer variability. Manually grading DR is subjective, time-consuming, and inaccurate, with consensus among experts at a low 70-80% and throughput limited to 100-120 patients daily, far from the needs of large-scale screening. Deep learning, particularly Convolutional Neural Networks (CNNs), has proven effective in automated DR screening and grading, outperforming expert-level performance.",
  "summary": "Scientific Reports, Published online: 05 August 2026; doi:10.1038/s41598-026-58690-w Clinical-guided deep learning framework for diabetic retinopathy: integrating lesion-aware attention, adversarial augmentation, and uncertainty quantification",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}